Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/25/20248:00AMInvestorsHub NewsWireAvant Technologies Addresses Progress on AI Supercomputer-Driven Data CentersUSOTC:AVAIAvant Technologies Inc (QB)
06/25/20248:00AMGlobeNewswire Inc.Stingray Delivers Popular Music and Concert Content to The Roku Channel in the US and CanadaRAY-B
06/25/20248:00AMGlobeNewswire Inc.Mintec Rebrands as Expana, Unifying Group Identities into a Singular Market Intelligence Powerhouse
06/25/20248:00AMBusiness WireMeadow Partners Raises $530 Million of New Capital Commitments
06/25/20248:00AMGlobeNewswire Inc.Stingray Delivers Popular Music and Concert Content to The Roku Channel in the US and CanadaRAY-A
06/25/20248:00AMGlobeNewswire Inc.Mintec devient Expana et fait fusionner les identités du groupe en un acteur majeur de l’information commerciale
06/25/20248:00AMGlobeNewswire Inc.Majority of Supply Chain Leaders Plan to Embrace New Technology to Overcome Persistent Challenges, TrueCommerce Survey Reveals
06/25/20248:00AMGlobeNewswire Inc.Pacific Green enters Polish energy storage market with double acquisition
06/25/20248:00AMGlobeNewswire Inc.Stingray Delivers Popular Music and Concert Content to The Roku Channel in the US and CanadaTSX:RAY.AStingray Group Inc
06/25/20248:00AMGlobeNewswire Inc.Stingray Delivers Popular Music and Concert Content to The Roku Channel in the US and CanadaTSX:RAY.BStingray Group Inc
06/25/20248:00AMGlobeNewswire Inc.Mintec führt Rebranding zu Expana durch und vereinigt Gruppenidentitäten zu führendem Unternehmen für Marktwissen
06/25/20248:00AMGlobeNewswire Inc.Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian CancerNASDAQ:ALLRAllarity Therapeutics Inc
06/25/20248:00AMBusiness WirePipeliner CRM Launches Voyager AI Gen II
06/25/20248:00AMGlobeNewswire Inc.8 Rivers Appoints Asheley Kinsey as New Chief Financial Officer
06/25/20247:57AMPR Newswire (US)Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression
06/25/20247:57AMPR Newswire (US)Metabolon Receives NIH Grant to Develop Advanced Monitoring and Predictive Tools for Type 1 Diabetes Progression
06/25/20247:56AMAlliance NewsAlliance NewsIN BRIEF: Syncona Chair & CEO Hollowood buys GBP100,000 in sharesLSE:SYNCSyncona Limited
06/25/20247:56AMAlliance NewsAlliance NewsIN BRIEF: Manchester & London IT says investment manager buys sharesLSE:MNLManchester & London Investment Trust Plc
06/25/20247:55AMAlliance NewsAlliance NewsIN BRIEF: Well positioned Huddled Group sees quarterly revenue jumpLSE:HUDHuddled Group Plc
06/25/20247:54AMGlobeNewswire Inc.Form 8.3 - Keywords Studios plc - Octopus Investments
06/25/20247:53AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJJP Morgan Alerian MLP
06/25/20247:48AMPR Newswire (Canada)Runergy Celebrates Successful Showcase at Intersolar Europe 2024
06/25/20247:48AMPR Newswire (US)Runergy Celebrates Successful Showcase at Intersolar Europe 2024
06/25/20247:46AMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]AMEX:AMJJP Morgan Alerian MLP
06/25/20247:45AMBusiness WireIndustrial Credit Union Selects Mahalo Banking to Drive Ongoing Innovation
06/25/20247:45AMPR Newswire (Canada)AtkinsRéalis Designing New York City Transit Broadway Junction Disability Access ImprovementsTSX:ATRLAtkinsRealis Group Inc
06/25/20247:45AMPR Newswire (US)Manasquan Bank Named Number One in New Jersey on Forbes' List of "America's Best-In-State Banks" for 2024
06/25/20247:45AMPR Newswire (Canada)AtkinsRéalis réalisera les améliorations de la Broadway Junction de New York pour optimiser l'accès pour les personnes handicapéesTSX:ATRLAtkinsRealis Group Inc
06/25/20247:45AMPR Newswire (US)QurAlis Expands its Industry-Leading Precision Medicine Approach in Splicing Targets Beyond Neurodegeneration Into Fragile X Syndrome (FXS)
06/25/20247:43AMGlobeNewswire Inc.Junshi Biosciences Announces Approval of the sNDA for Toripalimab for the 1st-Line Treatment of Advanced TNBC